Mass-balance Study of [14C]-APD421 in Healthy Volunteers
Status:
Completed
Trial end date:
2016-08-01
Target enrollment:
Participant gender:
Summary
Open-label, non-randomised, single dose study in 6 healthy male subjects to assess the mass
balance recovery, metabolite profile, metabolite identification and pharmacokinetics of
14C-labelled APD421